265 related articles for article (PubMed ID: 25798835)
1. YAP forms autocrine loops with the ERBB pathway to regulate ovarian cancer initiation and progression.
He C; Lv X; Hua G; Lele SM; Remmenga S; Dong J; Davis JS; Wang C
Oncogene; 2015 Dec; 34(50):6040-54. PubMed ID: 25798835
[TBL] [Abstract][Full Text] [Related]
2. The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.
He C; Mao D; Hua G; Lv X; Chen X; Angeletti PC; Dong J; Remmenga SW; Rodabaugh KJ; Zhou J; Lambert PF; Yang P; Davis JS; Wang C
EMBO Mol Med; 2015 Nov; 7(11):1426-49. PubMed ID: 26417066
[TBL] [Abstract][Full Text] [Related]
3. YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis.
Guerrant W; Kota S; Troutman S; Mandati V; Fallahi M; Stemmer-Rachamimov A; Kissil JL
Cancer Res; 2016 Jun; 76(12):3507-19. PubMed ID: 27216189
[TBL] [Abstract][Full Text] [Related]
4. YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway.
Wang C; Gu C; Jeong KJ; Zhang D; Guo W; Lu Y; Ju Z; Panupinthu N; Yang JY; Gagea MM; Ng PK; Zhang F; Mills GB
Cancer Res; 2017 Apr; 77(7):1637-1648. PubMed ID: 28202507
[TBL] [Abstract][Full Text] [Related]
5. M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop.
Carroll MJ; Kapur A; Felder M; Patankar MS; Kreeger PK
Oncotarget; 2016 Dec; 7(52):86608-86620. PubMed ID: 27888810
[TBL] [Abstract][Full Text] [Related]
6. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
Zhi X; Zhao D; Zhou Z; Liu R; Chen C
Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
[TBL] [Abstract][Full Text] [Related]
7. YAP promotes ovarian cancer cell tumorigenesis and is indicative of a poor prognosis for ovarian cancer patients.
Xia Y; Chang T; Wang Y; Liu Y; Li W; Li M; Fan HY
PLoS One; 2014; 9(3):e91770. PubMed ID: 24622501
[TBL] [Abstract][Full Text] [Related]
8. GEP oncogene promotes cell proliferation through YAP activation in ovarian cancer.
Yagi H; Asanoma K; Ohgami T; Ichinoe A; Sonoda K; Kato K
Oncogene; 2016 Aug; 35(34):4471-80. PubMed ID: 26804165
[TBL] [Abstract][Full Text] [Related]
9. YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells.
Hua G; Lv X; He C; Remmenga SW; Rodabough KJ; Dong J; Yang L; Lele SM; Yang P; Zhou J; Karst A; Drapkin RI; Davis JS; Wang C
Oncogene; 2016 Apr; 35(17):2247-65. PubMed ID: 26364602
[TBL] [Abstract][Full Text] [Related]
10. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
[TBL] [Abstract][Full Text] [Related]
11. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
12. PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin β2 expression.
Liu H; Dai X; Cao X; Yan H; Ji X; Zhang H; Shen S; Si Y; Zhang H; Chen J; Li L; Zhao JC; Yu J; Feng XH; Zhao B
EMBO Rep; 2018 Jun; 19(6):. PubMed ID: 29669796
[TBL] [Abstract][Full Text] [Related]
13. Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer.
Schrevel M; Osse EM; Prins FA; Trimbos JBMZ; Fleuren GJ; Gorter A; Jordanova ES
Int J Oncol; 2017 Jun; 50(6):1947-1954. PubMed ID: 28498437
[TBL] [Abstract][Full Text] [Related]
14. An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells.
Sheng Q; Liu X; Fleming E; Yuan K; Piao H; Chen J; Moustafa Z; Thomas RK; Greulich H; Schinzel A; Zaghlul S; Batt D; Ettenberg S; Meyerson M; Schoeberl B; Kung AL; Hahn WC; Drapkin R; Livingston DM; Liu JF
Cancer Cell; 2010 Mar; 17(3):298-310. PubMed ID: 20227043
[TBL] [Abstract][Full Text] [Related]
15. Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma.
Lee BS; Park DI; Lee DH; Lee JE; Yeo MK; Park YH; Lim DS; Choi W; Lee DH; Yoo G; Kim HB; Kang D; Moon JY; Jung SS; Kim JO; Cho SY; Park HS; Chung C
Biochem Biophys Res Commun; 2017 Sep; 491(2):493-499. PubMed ID: 28684311
[TBL] [Abstract][Full Text] [Related]
16. Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.
Byeon SJ; Lee HS; Kim MA; Lee BL; Kim WH
Pathobiology; 2017; 84(4):210-217. PubMed ID: 28399526
[TBL] [Abstract][Full Text] [Related]
17. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo.
Zhou ZN; Sharma VP; Beaty BT; Roh-Johnson M; Peterson EA; Van Rooijen N; Kenny PA; Wiley HS; Condeelis JS; Segall JE
Oncogene; 2014 Jul; 33(29):3784-93. PubMed ID: 24013225
[TBL] [Abstract][Full Text] [Related]
18. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
19. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation.
Cheng JC; Wang EY; Yi Y; Thakur A; Tsai SH; Hoodless PA
Mol Cancer Res; 2018 Oct; 16(10):1543-1555. PubMed ID: 29903770
[TBL] [Abstract][Full Text] [Related]
20. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
